Jakob Begun, MD, PhD

Mater Health, Australia

Poster(s):

• D0390 - Pilot Study to Assess Pharmacokinetic and Pharmacodynamic Markers Following Enema-Dosing With Adalimumab in Patients With Active Ulcerative Colitis (UC)
  Tuesday, October 25, 2022

  10:00 AM – 12:00 PM ET